Monitoring the AD effects of ketamine in MDD patients

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-510891-20-00

Acronym

CHDR2356

Enrollment

Registered

2024-05-17

Start date

Unknown

Completion date

2024-12-03

Last updated

2024-07-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major depressive disorder

None listed

Sex/Gender

All

Age

18 Years to No maximum

Netherlands

None listed

Source: EU CTIS · Data processed: Feb 4, 2026